(Q58190143)

7

object named as

M Wahren-Herlenius

0 references

author name string

M Kvarnström

1

0 references

V Dzikaite-Ottosson

2

0 references

L Ottosson

3

0 references

JT Gustafsson

4

0 references

I Gunnarsson

Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices

5

0 references

publication date

April 2013

0 references

published in

Lupus

0 references

volume

22

0 references

issue

5

0 references

page(s)

477-485

0 references

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Themes and variations on ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Self protection from anti-viral responses--Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Structurally derived mutations define congenital heart block-related epitopes within the 200-239 amino acid stretch of the Ro52 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Pathogenicity and proteomic signatures of autoantibodies to Ro and La.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Clinical and serologic factors associated with lupus pleuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420

The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203313479420